Month: March 2022

Canadian nonprofits are investing in digital transformation to drive efficiency and growth, Sage study finds

Written by Customer Service on March 24, 2022. Posted in Public Companies.

Pandemic has pushed organizations to seek new ways to work and deliver services TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses, today released a new study on the Canadian nonprofit sector, Grow Together: How digital transformation empowers Canadian nonprofit organizations to embrace change. The study found that nonprofits have seized the opportunity during the pandemic to rethink and change the way they operate to gain efficiencies and better serve their communities, despite the difficulties caused by COVID-19. Transforming operations to overcome challenges In partnership with Leger, a Canadian research firm, Sage found that 9 in 10 nonprofits consider their digital transformation efforts a top priority to update business...

EVmo Expands Fleet through Agreements with Leading OEMs to Supply Vehicles in Support of Growth Quarterly Plans

Written by Customer Service on March 24, 2022. Posted in Public Companies.

LOS ANGELES, March 24, 2022 (GLOBE NEWSWIRE) — EVmo, Inc. (OTC: YAYO) (the “Company’), a leading provider of vehicles to the rideshare and delivery gig economy industry, today announced a agreements with leading automobile manufacturers to supply the Company with approximately 400 new vehicles quarterly. “We are thrilled to have agreements with multiple leading OEMs to provide a steady supply of new vehicles to grow our fleet, an important component of our expansion strategy as we enter new markets in the months ahead,” commented Steven Sanchez, CEO of EVmo. “The commitments for these vehicles were made possible by the non-dilutive financing we announced earlier in March. These agreements give us tremendous confidence in our ability to achieve our goal of adding 400 vehicles to our fleet each quarter during 2022. This month’s order...

Aspo Plc – Managers’ transactions – Arto Meitsalo

Written by Customer Service on March 24, 2022. Posted in Public Companies.

Aspo Plc Managers’ transactionsMarch 24, 2022, at 3 p.m. Aspo Plc – Managers’ transactions – Arto Meitsalo Person subject to the notification requirement Name: Meitsalo Arto Position: Chief Financial Officer Issuer: Aspo Oyj LEI: 7437000TB0GHDHLPX677 Notification type: INITIAL NOTIFICATION Reference number: 7437000TB0GHDHLPX677_20220322131347_2 ____________________________________________ Transaction date: 2022-03-23 Venue not applicable Instrument type: SHARE ISIN: FI0009008072 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION Transaction details (1): Volume: 9,900 Unit price: EUR Aggregated transactions (1): Volume: 9,900 Volume weighted average price: EUR Aspo Plc Rolf Jansson CEO Further information, please contact: Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, rolf.jansson@aspo.com Distribution:...

IQST – iQSTEL Announces 3 Target Acquisitions Expected To Close Next Month

Written by Customer Service on March 24, 2022. Posted in Public Companies.

New York, NY, March 24, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today announced the company expects to close three acquisitions prior to the end of April 2022. CEO Leandro Iglesias has issued a update today as part of his regular series of updates detailing the company’s ongoing progress toward its $90 million 2022 annual revenue forecast and uplisting to Nasdaq in the first half of this year. The update is included in its entirety below: Dear Shareholders: The first fiscal quarter of 2022 is drawing to a conclusion and in spite of the prevailing market conditions and world events, I am pleased to share that iQSTEL is well on track to achieve its 2022 objectives. Nothing is standing in the way of our $90 million 2022 annual revenue forecast or Nasdaq uplisting. Permit me to share some highlights. Our new electric vehicle...

Non-Executive Director – External Appointment

Written by Customer Service on March 24, 2022. Posted in Public Companies.

NON-EXECUTIVE DIRECTOR – EXTERNAL APPOINTMENT London, 24 March 2022 – Endeavour Mining plc (LSE: EDV) (“the Company”) announces, in accordance with UK Listing Rule 9.6.14, that Alison Baker, an independent non-executive director of the Company, has notified the Company that she has been appointed to the board of Capstone Copper Corporation, a company admitted to trading on the Toronto Stock Exchange, with effect from 23 March 2022. CONTACT INFORMATIONEndeavour Mining Martino De CiccioVice President – Strategy & Investor Relations+44 203 640 8665mdeciccio@endeavourmining.com Brunswick Group LLP in LondonCarole Cable, Partner+44 7974 982 458ccable@brunswickgroup.com Vincic Advisors in TorontoJohn Vincic, Principal+1 647 402 6375john@vincicadvisors.comABOUT ENDEAVOUR MINING PLC Endeavour is one...

InflaRx Reports Full Year 2021 Financial and Operating Results

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Company received corrected FDA advice letter for Phase III trial with vilobelimab in hidradenitis suppurativa Positive Phase IIa data reported with vilobelimab in pyoderma gangrenosum; data being presented as late-breaker oral presentation at AAD Annual Meeting Topline data in vilobelimab Phase III trial in severe COVID-19 expected by end of March Both US and EU Phase II trials with vilobelimab in AAV met their objectives Phase II trial with vilobelimab in cSCC enrolling with first efficacy data expected later this year New program, INF904 oral small molecule inhibitor of C5aR, recently introduced Year-end cash and cash equivalents of approximately €26.2 million and financial assets of approximately €84.4 millionJENA, Germany, March 24, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company...

Pieridae Releases Q4 and 2021 Results

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Upstream Focused Company with a Viable LNG OptionNew President & COO and CFO Promotions Announced NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES Key Highlights:Generated $57.7 million Adjusted Funds Flow from Operations1 (“AFFO”) in 2021 an increase of 115% year over year from $26.9 million in 2020 to $57.7 million Generated $84.1 million Net Operating Income1 (“NOI”) in 2021, an increase of 66% year over year, from $50.7 million in 2020 Increased petroleum and natural gas revenue to $334.7 million in 2021 up 41% from $238.1 million in 2020 Production averaged 40,562 barrels of oil equivalent per day (“boe/d”) in 2021 , a marginal decrease from 42,000 boe/d in 2020 in the midst of two planned facility turnarounds or planned maintenance shutdowns The proved developed producing (“PDP”) base...

Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced its financial results for the fourth quarter and for the year ended December 31, 2021 and provided a corporate update. Chris Seto, CEO of Spectral Medical, commented, “2021 was a foundational year for Spectral and Dialco as we reported key achievements, both clinically and operationally, despite the headwinds presented by several waves of COVID variants. While clinical enrollment activity continued to be negatively impacted, the Company responded quickly...

FactSet Reports Results for Second Quarter 2022

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

Q2 revenues of $431.1 million, up 10.0% from Q2 2021 Organic Q2 ASV plus professional services of $1.7 billion, up 9.4% year over year Operating margin of 28.6% and adjusted operating margin of 33.7% Diluted EPS of $2.84, up 13.6% from the prior year; adjusted diluted EPS of $3.27, a 20.2% increase from the prior year. Completed CUSIP Global Services acquisition on March 1, 2022 for $1.925 billion, financed in part by our investment grade inaugural senior notes offering of $1.0 billion FactSet Investor Day will be held on April 5, 2022 in New York CityNORWALK, Conn., March 24, 2022 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced results for its second quarter...

Knight Therapeutics Reports Fourth Quarter and Year-End 2021 Results and Provides 2022 Revenue Guidance

Written by Customer Service on March 24, 2022. Posted in Earnings Releases And Operating Results.

MONTREAL, March 24, 2022 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading Pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2021. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified. 2021 Highlights FinancialsRevenues were $243,478, an increase of $43,959 or 22% over prior year. Gross margin of $115,412 or 47% compared to $81,690 or 41% in prior year. Adjusted EBITDA1 was $38,005, an increase of $21,168 or 126% over prior year. Net gain on financial assets measured at fair value through profit or loss of $18,944. Net income was $15,675, compared to net income of $31,760 in prior year. Cash inflow from operations...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals